These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7333059)

  • 21. Effects of ranitidine on the disposition of metoprolol.
    Kelly JG; Salem SA; Kinney CD; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1985 Feb; 19(2):219-24. PubMed ID: 3986080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel galactose single point method as a measure of residual liver function: example of cefoperazone kinetics in patients with liver cirrhosis.
    Hu OY; Tang HS; Chang CL
    J Clin Pharmacol; 1995 Mar; 35(3):250-8. PubMed ID: 7608313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of metoprolol in healthy, elderly, non-smoking individuals after a single dose and two weeks of treatment.
    Larsson M; Landahl S; Lundborg P; Regårdh CG
    Eur J Clin Pharmacol; 1984; 27(2):217-22. PubMed ID: 6499900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis.
    Hayton WL; Kneer J; Blouin RA; Stoeckel K
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1318-22. PubMed ID: 2386364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rhesus monkey as a model for studies of pregnancy induced changes in metoprolol metabolism.
    Högstedt S; Lindberg BS; Regårdh CG; Moström U; Rane A
    Pharmacol Toxicol; 1990 Jan; 66(1):32-6. PubMed ID: 2308905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of betaxolol in middle aged patients.
    Bianchetti G; Thiercelin JF; Thenot JP
    Eur J Clin Pharmacol; 1986; 31(2):231-3. PubMed ID: 2879735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis.
    Schwartz S; Brater DC; Pound D; Green PK; Kramer WG; Rudy D
    Clin Pharmacol Ther; 1993 Jul; 54(1):90-7. PubMed ID: 8330470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic interaction between verapamil and metoprolol in the dog. Stereochemical aspects.
    Murthy SS; Nelson WL; Shen DD; Power JM; Cahill CM; McLean AJ
    Drug Metab Dispos; 1991; 19(6):1093-100. PubMed ID: 1687016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of promazine in patients with hepatic cirrhosis--correlation with a novel galactose single point method.
    Hu OY; Tang HS; Sheeng TY; Chen TC; Curry SH
    J Pharm Sci; 1995 Jan; 84(1):111-4. PubMed ID: 7714731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J; Smith RP; Ferguson RA
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioavailability and elimination of nitrendipine in liver disease.
    Dylewicz P; Kirch W; Santos SR; Hutt HJ; Mönig H; Ohnhaus EE
    Eur J Clin Pharmacol; 1987; 32(6):563-8. PubMed ID: 3653225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics of metoprolol.
    Regårdh CG; Johnsson G
    Clin Pharmacokinet; 1980; 5(6):557-69. PubMed ID: 7002420
    [No Abstract]   [Full Text] [Related]  

  • 33. Temazepam clearance unaltered in cirrhosis.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Matlis R
    Am J Gastroenterol; 1986 Jan; 81(1):80-4. PubMed ID: 2867675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis.
    Orlando R; Sawadogo A; Miglioli PA; Cappellazzo MG; Palatini P
    Chemotherapy; 1992; 38(1):1-6. PubMed ID: 1617997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxmetidine (SK&F 92994): pharmacokinetic study in patients with in patients with liver cirrhosis.
    Miglio F; Baraldini M; Serra S; Facchini A; Stefanini GF; Meliconi R; Gasbarrini G; Labo' G
    Int J Clin Pharmacol Res; 1985; 5(6):399-404. PubMed ID: 2869000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.
    Godbillon J; Gerardin A; John VA; Theobald W
    Eur J Clin Pharmacol; 1983; 24(5):655-60. PubMed ID: 6873146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of pantoprazole in man.
    Huber R; Hartmann M; Bliesath H; Lühmann R; Steinijans VW; Zech K
    Int J Clin Pharmacol Ther; 1996 May; 34(5):185-94. PubMed ID: 8738854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
    Hasselström J; Eriksson S; Persson A; Rane A; Svensson JO; Säwe J
    Br J Clin Pharmacol; 1990 Mar; 29(3):289-97. PubMed ID: 2310653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiopental pharmacokinetics in patients with cirrhosis.
    Pandele G; Chaux F; Salvadori C; Farinotti M; Duvaldestin P
    Anesthesiology; 1983 Aug; 59(2):123-6. PubMed ID: 6869869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.